Spinal Cord Stimulator
Q&A: Spinal cord stimulation system offers nonopioid solution to pain management
The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to interim results of the BENEFIT-03 study.
Pilot study of spinal cord stimulation shows promise for gait disturbance in Parkinson’s
ORLANDO, Fla. — A pilot study of direct spinal cord stimulation showed promise for improving motor function in a small cohort of individuals with gait freezing in Parkinson’s disease, according to a presenter.
FDA expands indication for spinal cord stimulation system to cover nonsurgical back pain
The FDA has expanded approval for Boston Scientific’s WaveWriter spinal cord stimulation system to include treatment of chronic low back and leg pain in patients who have not had previous back surgery.
Diabetic neuropathy pain relief with spinal cord stimulator sustained at 24 months
An implanted 10 kHz spinal cord stimulator plus conventional management was associated with pain relief and quality of life improvements at 2 years for adults with painful diabetic neuropathy, according to study findings.
Spinal cord stimulation advances therapy for painful diabetic peripheral neuropathy
Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to severe pain related to the condition.
FDA approves spinal cord stimulation system for broad treatment of chronic pain
The FDA has granted premarket approval for Abbott’s Proclaim Plus spinal cord stimulation system, which can treat chronic pain across up to six areas of the body and is programmable to adjust to a person’s needs, the company announced in a release.
Spinal cord stimulator improves quality of life in painful diabetic neuropathy
Treatment combining an implanted 10 kHz spinal cord stimulator and conventional care yielded better quality of life for adults with painful diabetic neuropathy, according to study findings.
Pain relief from spinal cord stimulation in diabetic neuropathy sustained at 18 months
SAN DIEGO — Spinal cord stimulation reduces pain and improves quality of life for at least 18 months for most adults with painful diabetic neuropathy, according to a speaker here.
FDA approves spinal cord stimulation for diabetic peripheral neuropathy chronic pain
The FDA approved the use of a spinal cord stimulation therapy for the treatment of chronic pain caused by diabetic peripheral neuropathy, according to a press release from Medtronic.